EUVIMEDEUVIMED entdecken
Open Access

Changes in clinic visits and diabetes and metabolic control in patients with type 2 diabetes during COVID-19 pandemic: A real world evidence

Fatemeh Bandarian, Mostafa Qorbani, Maryam Aalaa, Maryam Peimani, Bagher Larijani, Ensieh Nasli-Esfahani

Primary Care Diabetes · 2023

DOI: 10.1016/j.pcd.2023.03.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Primary Care Diabetes, 2023. Verfasst von Fatemeh Bandarian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Metabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences,…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The study aim was to evaluate the effects of public lockdown during the covid-19 pandemic on glucose and metabolic parameters as well as body weight control in type 2 diabetic patients. METHODS: This study was conducted in two outpatient Diabetes Clinics and analyzed data available in database of Diabetes Clinic. Data related to a year before covid-19 pandemic and a year during covid-19 pandemic was collected from the database and analyzed. Patients with type 2 diabetes included in the analysis if they had referred to Diabetes Clinics both before and during covid-19 pandemic. Demographic information and data about metabolic status were collected from the records of previous outpatient Clinic visits and compared RESULTS: Finally 9440 patients with mean age of 61.08 ± 11.62 referred to Diabetes Clinics in both the year before and the year of the corona pandemic. Mean FBS and HbA1c in diabetes patients reduced significantly from 155.37 ± 62.93 and 7.97 ± 1.74 before pandemic, respectively to 138.77 ± 45.39 and 7.54 ± 1.34, respectively during covid-19 outbreak. During covid-19 pandemic, all metabolic parameters including glycemic and lipid profile (except for triglyceride) and BMI (body mass index) reduced significantly statistically, but, these changes were not clinically significant. However, triglyceride level increased statistically significantly but again it was not significant clinically. CONCLUSION: During COVID-19 lockdown, glycemic and metabolic control of diabetes patients have improved significantly except for triglycerides.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2COVID-19HumansMiddle AgedAgedPandemicsBlood GlucoseCommunicable Disease ControlTriglyceridesAmbulatory Care

Stichwörter der Autor:innen

COVID-19Glycemic controlMetabolic controlType 2 diabetes

Substanzen

Blood GlucoseTriglycerides

Autor:innen und Institutionen

  • Metabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.
  • Non-communicable Disease Research Center, Alborz University of Medical Sciences, Karaj, Islamic Republic of Iran.
  • Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.
  • Evidence-Based Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.
  • Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.
  • Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran. Electronic address: e-nasli@sina.tums.ac.ir.

Förderung

  • Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences

Zitieren

APA

Bandarian, F., Qorbani, M., Aalaa, M., Peimani, M., Larijani, B., & Nasli-Esfahani, E. (2023). Changes in clinic visits and diabetes and metabolic control in patients with type 2 diabetes during COVID-19 pandemic: A real world evidence. Primary Care Diabetes. https://doi.org/10.1016/j.pcd.2023.03.004

Vancouver

Bandarian F, Qorbani M, Aalaa M, Peimani M, Larijani B, Nasli-Esfahani E. Changes in clinic visits and diabetes and metabolic control in patients with type 2 diabetes during COVID-19 pandemic: A real world evidence. Primary Care Diabetes. 2023. doi:10.1016/j.pcd.2023.03.004

BibTeX
@article{Bandarian2023,
  author = {Bandarian, Fatemeh and Qorbani, Mostafa and Aalaa, Maryam and Peimani, Maryam and Larijani, Bagher and Nasli-Esfahani, Ensieh},
  title = {Changes in clinic visits and diabetes and metabolic control in patients with type 2 diabetes during COVID-19 pandemic: A real world evidence},
  journal = {Primary Care Diabetes},
  year = {2023},
  doi = {10.1016/j.pcd.2023.03.004}
}
Kostenlos starten →